Home » Takeda Slaps Hetero With Lawsuit Blocking Its Generic Actos
Takeda Slaps Hetero With Lawsuit Blocking Its Generic Actos
Takeda Pharmaceuticals is suing Hetero Drugs and two subsidiaries to bar them from marketing generic versions of Type 2 diabetes drug Actos.
Generic Line
Generic Line
Upcoming Events
-
07May
-
14May
-
30May